Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Heart transplantation Stories

2013-06-04 10:20:51

New study demonstrates significant mortality rate among non-adhering adolescent patients and identifies risk factors that lead to non-adherence After receiving an organ transplant, patients must follow a regimented medication routine to maintain the health of their graft (transplanted organ). Failure to do so, known as non-adherence (NA), can result in life-threatening illness. NA has long been a concern among adolescent patients, but a new study from Boston Children's Hospital...

2013-05-30 08:24:36

35-Year-Old Father of Four Returns Home with New Donor Heart to New Baby Boy TUCSON, Ariz., May 30, 2013 /PRNewswire/ -- When Justin Ryder, 35, was discharged from University of Arizona Medical Center in Tucson on May 20, he had a new donor heart beating in his chest and a new baby boy waiting for him at home in Las Vegas, his heart transplant made possible by 83 days of life with the SynCardia temporary Total Artificial Heart. (Photo:...

2013-05-24 23:29:56

115 Interactive Exhibits, Research Capsules and Live Laboratory Experiences Explore the Science of Health and Wellbeing in the 21st Century Tucson, Ariz. (PRWEB) May 23, 2013 SynCardia Systems, Inc. (http://www.syncardia.com), manufacturer of the world´s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that the Glasgow Science Centre in Scotland, which boasts more than 380,000 visitors annually, is featuring the SynCardia temporary...

2013-05-16 08:29:20

Dr. Jack Copeland Recognized for His Landmark Contributions in the Field of Heart Transplantation TUCSON, Ariz., May 16, 2013 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that world-renowned heart surgeon and SynCardia co-founder Jack G. Copeland, MD, was awarded the prestigious Pioneer in Transplantation Award at the annual meeting of the...

2013-05-09 08:30:26

Bedridden for Months, 41-Year-Old Father of Five Was Walking Again Two Weeks after Implant TUCSON, Ariz., May 9, 2013 /PRNewswire/ -- When Alfred Williams was admitted to Ochsner Medical Center in December, the 41-year-old father of five had exhausted all treatment options for his enlarged heart. His condition, known as dilated cardiomyopathy, had progressed to end-stage heart failure affecting both sides of his heart. Unable to walk, he had been confined to a bed for months. Hospice...

2013-04-25 12:27:37

World's Only Approved Total Artificial Heart Surpasses 500 Implants in the U.S. TUCSON, Ariz., April 25, 2013 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that a record 40 implants of the SynCardia temporary Total Artificial Heart were performed at 24 SynCardia Certified Centers during the quarter ended March 31, 2013. (Photo:...

2013-04-18 08:30:30

Greg Rathe, 42, Waits for Second Heart Transplant after Rejecting the Donor Heart He Received 17 Years Ago TUCSON, Ariz., April 18, 2013 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that The Nebraska Medical Center in Omaha has performed the state's first implant of the SynCardia temporary Total Artificial Heart to save the life of 42-year-old...

2013-04-11 12:30:37

Topics Include Home Discharge Using the Freedom® Portable Driver and Use of the Total Artificial Heart for Adolescents, Congenital Patients and Destination Therapy TUCSON, Ariz., April 11, 2013 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that more than 20 SynCardia Certified Centers representing four countries and more than 70 authors...

2013-04-04 08:28:25

In-Hospital Power Supply for the SynCardia Total Artificial Heart Supports Patients Until They Are Stable and Switched to the Freedom® Portable Driver TUCSON, Ariz., April 4, 2013 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), the privately-held manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that its Companion 2 (C2) Driver System, which powers the SynCardia temporary Total Artificial...

2013-03-21 08:31:06

Total Artificial Heart Was Only Option to Save Patient with Extensive Thrombus in Left Ventricle TUCSON, Ariz., March 21, 2013 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Andrew Weaver, a 31-year-old husband and father of one who arrived at Intermountain Medical Center in Salt Lake City in grave condition, has been successfully bridged...


Latest Heart transplantation Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »